Timeliness of antiresorptive consolidation after anabolic therapy for primary fracture prevention: A US cohort study
Only 1 in 4 patients received timely consolidation therapy after osteoanabolic treatment, and 1 in 8 completed the full sequence. Strategies to improve consolidation in primary fracture prevention are needed.
Authors
- Rozalina Grubina McCoy (ORCID: https://orcid.org/0000-0002-2289-3183)
- Jeph Herrin (ORCID: https://orcid.org/0000-0002-3671-3622)
- Juan Pablo Brito (ORCID: https://orcid.org/0000-0003-1840-1745)
- Alexander Everhart (ORCID: https://orcid.org/0000-0001-5192-6557)
- Joseph Theressa Nehu Parimi
- Robert A. Wermers (ORCID: https://orcid.org/0000-0002-9822-7881)
- Pinar Karaca Mandic
- Sanaa Badour
- Mark Takagi
- Clifford J Rosen
Institutions
- University of Maryland, Baltimore (US)
- University of Minnesota (US)
- Mayo Clinic (US)
- Washington University in St. Louis (US)
- Diabetes Australia (AU)
- Foundation for the National Institutes of Health (US)
- Yale University (US)
- MaineHealth (US)
- Optum (United States) (US)
- Mayo Clinic in Arizona (US)
- Baltimore VA Medical Center (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1210/clinem/dgag092
- Citations
- 1
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 39.58